These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3053889)

  • 1. Causality assessment of drug-induced liver injury. Hepatology Working Group.
    Danan G
    J Hepatol; 1988 Aug; 7(1):132-6. PubMed ID: 3053889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUCAM in Drug and Herb Induced Liver Injury: The Update.
    Danan G; Teschke R
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
    Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case definition and phenotype standardization in drug-induced liver injury.
    Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
    Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
    Danan G; Bénichou C; Begaud B; Biour M; Couzigou P; Evreux JC; Lagier G; Berthelot P; Benhamou JP
    Gastroenterol Clin Biol; 1987; 11(8-9):581-5. PubMed ID: 3308618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of drug-induced liver injury in clinical practice.
    Lucena MI; García-Cortés M; Cueto R; Lopez-Duran J; Andrade RJ
    Fundam Clin Pharmacol; 2008 Apr; 22(2):141-58. PubMed ID: 18353109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
    Benesic A; Leitl A; Gerbes AL
    Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced liver injury and drug development: industry perspective.
    Regev A
    Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States.
    Hayashi PH
    Int J Mol Sci; 2016 Feb; 17(2):201. PubMed ID: 26861284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic approach in cases of herbal hepatotoxicity].
    Teschke R; Schulze J; Eickhoff A
    Z Gastroenterol; 2012 Aug; 50(8):776-91. PubMed ID: 22895907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified diagnostic criteria of drug-induced liver injury proposed by the international consensus meeting.
    Iwasa M; Zeniya M; Kumagi T; Hisamochi A; Yasuda H; Nishiuchi M; Akisawa N; Mantani N; Watanabe M; Ito T; Nakamura A; Takikawa H; Adachi Y
    Hepatogastroenterology; 2005; 52(63):869-74. PubMed ID: 15966223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected Liver Injury and the Dilemma of Causality.
    Teschke R; Eickhoff A
    Dig Dis Sci; 2017 Apr; 62(4):1095-1098. PubMed ID: 28210906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
    Teschke R; Schmidt-Taenzer W; Wolff A
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver disease.
    Davern TJ
    Clin Liver Dis; 2012 May; 16(2):231-45. PubMed ID: 22541696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatotoxicity of drugs and chemicals].
    Larrey D
    Gastroenterol Clin Biol; 2009 Dec; 33(12):1136-46. PubMed ID: 19931994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.